Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Prabha Ranganathan

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Annals of the Rheumatic Diseases|March 7, 2013
Herpes zoster infection risk in patients with rheumatoid arthritis on tumour necrosis factor inhibitorsPrabha Ranganathan
Current Opinion in Molecular Therapeutics|December 4, 2008
An update on pharmacogenomics in rheumatoid arthritis with a focus on TNF-blocking agentsPrabha Ranganathan
BMJ (Clinical Research Ed.)|May 30, 2023
Monitoring methotrexate toxicity: Are we being over-vigilant?Prabha Ranganathan
Pharmacogenomics|April 4, 2008
An update on methotrexate pharmacogenetics in rheumatoid arthritisPrabha Ranganathan
Methods in Molecular Biology (Clifton, N.J.)|March 29, 2008
Pharmacogenomics in rheumatoid arthritisPrabha Ranganathan
Pharmacogenomics|April 10, 2012
Meta-analysis of MTHFR polymorphisms and MTX response in RAPrabha Ranganathan
Rheumatology International|July 10, 2015
Genetic variants influencing response to methotrexate in juvenile idiopathic arthritis and rheumatoid arthritisPrabha Ranganathan
Nature Reviews. Rheumatology|June 17, 2015
Rheumatoid arthritis: Biomarkers of response to TNF inhibition in RAPrabha Ranganathan
Pharmacogenomics|April 10, 2012
Genetic and nongenetic determinants of MTX efficacy in RAPrabha Ranganathan
Pharmacogenomics|March 3, 2012
The challenges of methotrexate pharmacogenetics in rheumatoid arthritisPrabha Ranganathan
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Annals of the Rheumatic Diseases|March 7, 2013
Herpes zoster infection risk in patients with rheumatoid arthritis on tumour necrosis factor inhibitorsPrabha Ranganathan
Current Opinion in Molecular Therapeutics|December 4, 2008
An update on pharmacogenomics in rheumatoid arthritis with a focus on TNF-blocking agentsPrabha Ranganathan
BMJ (Clinical Research Ed.)|May 30, 2023
Monitoring methotrexate toxicity: Are we being over-vigilant?Prabha Ranganathan
Pharmacogenomics|April 4, 2008
An update on methotrexate pharmacogenetics in rheumatoid arthritisPrabha Ranganathan
Methods in Molecular Biology (Clifton, N.J.)|March 29, 2008
Pharmacogenomics in rheumatoid arthritisPrabha Ranganathan
Pharmacogenomics|April 10, 2012
Meta-analysis of MTHFR polymorphisms and MTX response in RAPrabha Ranganathan
Rheumatology International|July 10, 2015
Genetic variants influencing response to methotrexate in juvenile idiopathic arthritis and rheumatoid arthritisPrabha Ranganathan
Nature Reviews. Rheumatology|June 17, 2015
Rheumatoid arthritis: Biomarkers of response to TNF inhibition in RAPrabha Ranganathan
Pharmacogenomics|April 10, 2012
Genetic and nongenetic determinants of MTX efficacy in RAPrabha Ranganathan
Pharmacogenomics|March 3, 2012
The challenges of methotrexate pharmacogenetics in rheumatoid arthritisPrabha Ranganathan
Pageof 6